HIF1A and neoplasm: The expression of HIF-1α and PD-L1 down-regulated, resulting in enhanced CMT and immune response and inhibited the PD-1/PD-L1 axis, which significantly prolonged tumor recurrence time and inhibited tumor metastasis.